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Background: HIV/AIDS and Ebola Virus Disease (EVD) are contemporary epidemics associated with significant
social stigma in which communities affected suffer from social rejection, violence, and diminished quality of life.
Objective: To compare and contrast stigma related to HIV/AIDS and EVD, and strategically think how
lessons learned from HIV stigma can be applied to the current EVD epidemic.
Methods: To identify relevant articles about HIV/AIDS and EVD-related stigma, we conducted an extensive
literature review using multiple search engines. PubMed was used to search for relevant peer-reviewed journal
articles and Google for online sources. We also consulted the websites of the World Health Organization
(WHO), Centers for Disease Control and Prevention (CDC), and the National Institutes of Health to retrieve
up-to-date information about EVD and HIV/AIDS.
Results: Many stigmatizing attitudes and behaviors directed towards those with EVD are strikingly similar to
those with HIV/AIDS but there are significant differences worthy of discussion. Both diseases are life-threatening
and there is no medical cure. Additionally misinformation about affected groups and modes of transmission runs
rampant. Unlike in persons with EVD, historically criminalized and marginalized populations carry a dispro-
portionately higher risk for HIV infection. Moreover, mortality due to EVD occurs within a shorter time span as
compared to HIV/AIDS.
Conclusions: Stigma disrupts quality of life, whether it is associated with HIV infection or EVD. When addres-
sing EVD, we must think beyond the immediate clinical therapeutic response, to possible HIV implications of
serum treatment. There are emerging social concerns of stigma associated with EVD infection and double stigma
associated with EVD and HIV infection. Drawing upon lessons learned from HIV, we must work to empower and
mobilize prominent members of the community, those who recovered from the disease, and organizations working
at the grassroots level to disseminate clear and accurate information about EVD transmission and prevention while
promoting stigma reduction in the process. In the long run, education, prevention, and atherapeutic vaccine will be
the optimal solutions for reducing the stigma associated with both EVD and HIV.
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A
numberof diseases have had devastating impacts
oncommunities,societies,andcivilizationsthrough-
out history. The plague, cholera, and leprosy, for
instance, have contributed to substantial mortality and
morbidity around the world (1, 2). These diseases are also
particularly noteworthy for the social stigma they carry
andthepooroutcomesassociatedwiththatstigma(3,4,5).
More recent epidemics such as HIV/AIDS and Ebola
VirusDisease(EVD)havenotonlyledtosignificantlossof
life but also to stigma which has continued despite global
efforts to control both epidemics. Communities affected
by HIV/AIDS and EVD-related stigma have suffered
isolation and ostracism, physical violence, and diminished
quality of life (6). While multiple interventions to reduce
HIV/AIDS-related stigma have been developed and im-
plemented, prejudice and discrimination associated with
having EVD has received much less attention (7, 8). In this
paper, we draw upon lessons learned from HIV/AIDS-
related stigma reduction interventions and their possible
application to EVD.
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Early theorists of stigma including Erving Goffman in
his 1963 work ‘Notes on the Management of Spoiled
Identity’, defined stigma as ‘an attribute that is deeply
discrediting’ and one that precludes an individual from
full social acceptance (9). Furthermore, the stigmatized
person, as a result of this attribute, is reduced from a
whole individual to a tainted and discounted one (9).
Other definitions of stigma include an attribute or char-
acteristic that is contrary to a norm of a ‘social unit’ (10),
conveys a social identity that is devalued (11), and an
act of labeling, stereotyping, separation, status loss, and
discrimination of someone possessing that attribute or
characteristic (12). Stigma related to EVD and HIV/
AIDS refers to derogatory attitudes, beliefs, and beha-
viors directed toward people living with the diseases and
those presumed to be infected (8, 13, 14).
Similarities and Differences between
HIV/AIDS- and EVD-related Stigma
Stigma in the context of HIV/AIDS is a prevailing
stressor with incapacitating consequences (15). Historically,
HIV/AIDS has been attributed to personal irresponsibi-
lity and behaviors and lifestyles that are socially unac-
ceptable (16). However, diseases do not exist in a vacuum
but are products of broader structural processes such as
poverty, racism, and gender inequality (17, 18). These
factors individually and collectively shape human vulner-
ability to disease and its distribution as well as dictate
attitudes, beliefs, and behaviors toward certain groups
(16). In the context of HIV/AIDS, stigmatized groups
have included people who inject drugs, sex workers, and
men who have sex with men (14). Stigmatizing attitudes
and behaviors, including patient blaming and neglect,
refusal/denial of care, and irrational and inappropriate
fear of contagion directed toward impacted populations
have not only devastated familial, social, and economic
relationships and infrastructures but they have also inter-
fered and created colossal barriers to access, prevention,
and treatment (17, 1923). More specifically, HIV/AIDS-
related stigma has led to avoidance of healthcare, reduced
adherence to antiretroviral medications, increased HIV
symptomatology, and emergence of mental health pathol-
ogies including depression (15, 24, 25).
StigmainthecontextofEVDisequallydisconcertingas
it also originates from structural inadequacies, including
poverty, lack of education, and political conflict (26).
These factors combined with cultural practices subse-
quently influence attitudes, beliefs, and behaviors with
respect to disease transmission (27). During the 2000 and
2001 EVD epidemics in Uganda for example, harassment,
rejection, and abandonment of individuals with EVD
were common occurrences (8). Those in contact with
EVD patients were also victimized with some being
preventedfromreturningtotheirhomesandcommunities,
and their properties destroyed (28). Children were also
not spared. There are reports of children orphaned by
EVD who remain sero-negative but have not been taken
up for care by families and communities out of fear of
contagion (29).
As of October 15, 2014, the Centers for Disease Control
and Prevention (CDC) reported 8,973 cases of EVD in
West Africa and 4,484 deaths (30). The current epidemic
affects Liberia, Guinea, and Sierra Leone and has been
identified as the worst epidemic in the history of the
disease, with a survival rate of 53% (31, 32). Those who
have survived the current epidemic face the stigma of
having had EVD and this is consistent with previous
research findings (8, 28, 33). According to the Interna-
tional Federation of Red Cross and Red Crescent
Societies, individuals cured of EVD with certification of
clearance by medical authorities have been prohibited
from returning to their homes, and shunned by their
communities, friends, family, and co-workers (34). Some
survivors have also reported threats of violence from their
community (35, 36). Instances of civil unrest and violence
against healthcare workers and educators have also been
reported in addition to killings (37, 38).
Stigmatizing attitudes and behaviors directed towards
those with EVD are similar to HIV/AIDS in many im-
portant ways. For instance, the idea that EVD only affects
certain groups such as poor Africans and African im-
migrants is comparable to HIV/AIDS as it was attributed
tohomosexualityintheearlydaysoftheepidemic(39,40).
Additionally, EVD and HIV/AIDS have both been cate-
gorized as divine retribution for committing undesirable
acts (28, 41). Other similarities include irrational and
unfounded fear of contracting the pathogen through
mechanisms that have not been scientifically indicated,
stigmatization of people who associate with those living
with the diseases in question (13, 33, 42, 43) and the
perception that both diseases are the result of propaganda
for population control (44, 45).
Despite the aforementioned similarities, there are also
significant differences between EVD- and HIV/AIDS-
related stigma. Unlike EVD, persons who are already
criminalizedandstigmatizedbysociety(menwhohavesex
with men, male and female sex workers, and people who
inject drugs) are at disproportionately higher risk for HIV
infection(46).Also,whilesomepatientsareabletosurvive
EVD and clear the virus after some time, the stigma
associated with having had the disease is not alleviated
(8, 47, 48). In addition, EVD mortality occurs within a
short time span compared to HIV/AIDS and therefore
publicconcernaboutEVDinfectionremainselevated(49).
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from HIV, consider and perhaps apply strategies that have
shownpromise.Todisseminateaccurateinformationtocom-
munities impacted by EVD in ways that facilitate translation
of information into action, recruitment and training of
Popular Opinion Leaders (POL), may be beneficial (50).
POL include members of a community who are highly re-
spected and who may have the ability to mobilize people to
work for a common goal, in this case to fight stigma (51).
Multi-level community interventions that include accurate
informationaboutdiseasetransmission,skill-building,coun-
seling and support, and testimonials from persons who
survived the disease as well as those who took care of EVD
patients may also be effective (52). Collective strategies such
as social activism, capacity, resilience and skill building, and
empathy-based contact promoting programs have been
beneficial in the fight against HIV/AIDS-related stigma
and can be tailored for addressing EVD-related stigma
(13, 53, 54).
On a more broader scale, we must work diligently to
empower community and religious leaders, persons af-
fected by the disease, and organizations working at the
grassroots level to disseminate clear and concise informa-
tion about EVD transmission and prevention, while also
promoting stigma reduction (50). In developing countries,
including those affected by the current EVD epidemic,
community-based stigma reduction initiatives have been
far more effective in reducing HIV/AIDS-related stigma
than individual-level programs (55). Building on these
findings, we can construct, enhance, and evaluate similar
community-based programs for the reduction of stigma
associated with EVD (56). For those affected by EVD,
it would equally be important to address their capacity
to deal with the social stigma they have to face. Using
strategies like counseling, training on coping skills, and
promoting public contact with persons who have had
EVD in an effort at inducing empathy may help reduce
EVD-related stigma.
Inthelongrun,education,prevention,andatherapeutic
vaccine are the optimal solutions for reducing the stigma
associatedwithbothEVDandHIV.However,utilizingthe
aforementioned strategies as part of community-based
advocacy programs may help reduce EVD-related stigma.
This approach may be particularly feasible because major
donors and stakeholders such as the Gates Foundation,
CDC, NIH, and WHO are involved in HIV prevention
programs in affected countries are also currently assisting
with the EVD response.
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